Receive our newsletter – data, insights and analysis delivered to you
  1. News
March 26, 2020

Jefferies becomes first private-sector company to join RAPID initiative

US-based financial services company Jefferies announced yesterday that it will be joining the Rapid Aseptic Packaging of Injectable Drugs (RAPID) initiative.

By Jessica Paige

US-based financial services company Jefferies announced yesterday that it will be joining the Rapid Aseptic Packaging of Injectable Drugs (RAPID) initiative.

Jefferies is the first private-sector entity to join the initiative and will be providing it with access to private-sector capital markets, global financial resources, and an initial capital commitment of $10mn.

The RAPID initiative was launched by the US Department of Health and Human Services (HHS) and injectable medicines specialist ApiJect in response to the Covid-19 coronavirus outbreak. It will create emergency drug packaging using low-cost pre-filled syringes.

Jefferies CEO Rich Handler and president Brian Friedman said: “All of us at Jefferies are deeply concerned about, and personally impacted by, the Covid-19 coronavirus pandemic. We are ready to put the firm’s capital to work in smart solutions, such as RAPID, that are critically needed to help America and the world win the battle against this pandemic.

“We have always supported new and innovative approaches and we believe RAPID is the right public-private partnership as we face this crisis in both the short-term and long-term.”

They also commented that all leadership companies belong “on the front lines of the war against this global threat” and that, by supporting RAPID, Jefferies has taken that position.

Content from our partners
GMP: The food sector’s golden rules (and how they will evolve)
Food fraud in the supply chain (and how to fix it)
Cutting-edge innovation in fish packaging

ApiJect CEO Jay Walker said: “Given the urgency to bring back critical elements in the pharma manufacturing supply chain to the US, we are especially pleased to be leading the RAPID consortium. Drug packaging and dispensing at population scale within our borders will be essential to safeguard the American public quickly and safely.

“Winning this battle against COVID-19 requires each and every company, citizen and all levels of government to step up. Having Jefferies as RAPID’s initial, shoulder-to-shoulder supporter brings a global network of clients’ immediate seed capital and a deep and experienced team to expand RAPID’s management capabilities.

“Its substantial financial support signals to others in the investment community the vital and central role that RAPID, as a public-private partnership led by the HHS Assistant Secretary for Preparedness and Response, will play in the war against the current pandemic, as well as future health emergencies and threats.”

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The packaging industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU